Top ▲
Target id: 2279
Nomenclature: WEE2 oocyte meiosis inhibiting kinase
Abbreviated Name: WEE1B
Family: WEE family
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 567 | 7q34 | WEE2 | WEE2 oocyte meiosis inhibiting kinase | |
Mouse | - | 555 | 6 B1 | Wee2 | WEE1 homolog 2 (S. pombe) | |
Rat | - | - | 4q22 | Wee2 | WEE2 oocyte meiosis inhibiting kinase |
Previous and Unofficial Names ![]() |
WEE1 homolog 2 | wee1-like protein kinase 2 |
Database Links ![]() |
|
Alphafold | P0C1S8 (Hs), Q66JT0 (Mm) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL5095 (Hs) |
Ensembl Gene | ENSG00000214102 (Hs), ENSMUSG00000037159 (Mm), ENSRNOG00000026446 (Rn) |
Entrez Gene | 494551 (Hs), 381759 (Mm), 502750 (Rn) |
Human Protein Atlas | ENSG00000214102 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:494551 (Hs), mmu:381759 (Mm), rno:502750 (Rn) |
OMIM | 614084 (Hs) |
Pharos | P0C1S8 (Hs) |
RefSeq Nucleotide | NM_001105558 (Hs), NM_201370 (Mm) |
RefSeq Protein | NP_001099028 (Hs), NP_958758 (Mm) |
UniProtKB | P0C1S8 (Hs), Q66JT0 (Mm) |
Wikipedia | WEE2 (Hs) |
Enzyme Reaction ![]() |
||||
|
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: WEE2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
WEE family: WEE2 oocyte meiosis inhibiting kinase. Last modified on 12/11/2019. Accessed on 25/04/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2279.